Press Releases

Date	Title	PDF Version
Jan 07, 2019	Alexion to Report Fourth Quarter and Full Year 2018 Results on Monday, February 4, 2019
Jan 02, 2019	Alexion to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 21, 2018	Alexion to Present at the Goldman Sachs 11th Annual Healthcare CEO Conference
Dec 21, 2018	Alexion Receives Early FDA Approval for ULTOMIRIS™ (Ravulizumab-cwvz) in Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Dec 03, 2018	Comprehensive Positive Phase 3 Data for Alexion’s ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria Presented at American Society of Hematology (ASH) Annual Meeting and Published in Blood
Nov 20, 2018	Alexion to Present at the Evercore ISI Healthcare Conference
Nov 07, 2018	Alexion to Present at Credit Suisse’s 27th Annual Healthcare Conference
Nov 02, 2018	Alexion Completes Acquisition of Syntimmune
Nov 01, 2018	Alexion Announces Upcoming Data Presentations at American Society of Hematology Annual Meeting
Oct 24, 2018	Alexion Reports Third Quarter 2018 Results

Search